Biopharmaceutical research and development symposium nears

by Kalani Simpson, UNMC public relations | August 10, 2018

Image with caption: Ram Mahato, Ph.D., chair of pharmaceutical sciences

Ram Mahato, Ph.D., chair of pharmaceutical sciences

Speakers from MD Anderson Cancer Center, Harvard Medical School, Emory and St. Jude's Children's Research Hospital are among the headliners for the College of Pharmacy's fifth annual Biopharmaceutical Research and Development Symposium, set for Sept. 5-6.

The symposium will take place at the Truhlsen Events Center in the Michael F. Sorrell Center for Health Science Education. This year's theme is "Nanotechnology for Immunotherapy."

Ram Mahato, Ph.D., chair of pharmaceutical sciences, said this fifth symposium will explore application of these emerging technologies in the treatment of cancer.

"While chemotherapy continues to play a critical role in cancer treatment, immunotherapy and genome engineering are gaining increasing attention. Therefore, this symposium will cover different facets of cancer immunotherapies, including targeting of T cells, harnessing natural killer cells for therapeutic intervention, immunomodulatory discovery of small molecules, drug delivery strategies and pharmacokinetics/pharmacodynamics (PK/PD) analysis."

The symposium also will cover different facets of developing tools for nanomedicine, immunotherapy and cancer biology.

Thirteen speakers from UNMC and universities across the U.S. and India headline the event. The program also features oral presentations from the postdocs and graduate students, providing them with an opportunity to present their research to symposium attendees.

Through talks, a poster session and a panel of discussion, this meeting will help identify the scientific, clinical and regulatory hurdles to overcome.

For more information, a list of conference speakers, and to register, please click here.


Fill out the following and your comment will post once it has been approved.

Name (Required)

Email (Required)

Thank you, your comment will appear below once it has been approved.